Pharmaceutical Industry: Origin of new molecular entities
This statistic represents the origin of the 25 new molecular (chemical and biological) entities in the global pharmaceutical market in 2009.
You only have access to basic statistics.
Business Solutions including all features.
Overview
Segments
Companies
R&D, patents, new products
Outlook
Focus: COVID-19 response
Further related statistics